PROGRAM

Faculty and topics

Emilio Ambrosio, PhD
National University for Distance Learning (UNED), Madrid | Spain
“Analgesic and reinforcing properties of New Opioid Synthetic Isotonitazene”

Michael Baumann, PhD
Designer Drug Research Unit (DDRU) NIDA, NIH, Baltimore |USA
“New psychoactive substances in the US recent trends and pharmacological investigations”

Valeria Catalani, PhD student
Psychopharmacology, Drug Misuse & NPS Research Unit | University of Hertfordshire | UK
“In silico technologies: preliminary (risk)assessment on New Psychoactive Substances”

Gaetano Di Chiara, MD
University of Cagliari and Institute of Neuroscience National Research Council of Italy | Italy
“Preclinical findings from the JUSTSO European project”

Michael Evans-Brown
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon | Portugal
“25 years of early warning and response in Europe: Where are we with new psychoactive substances?”

Magin Farré, MD, PhD
Hospital Universitari Germans Trias i Pujol (HUGTiP, IGTP). Universitat Autònoma de Barcelona | Spain
“Drug Interactions With Novel Synthetic Opioids”

Raffaele Giorgetti, MD
University “Politecnica delle Marche” | Italy
“Analytical challenges in the detection of Novel Synthetic Opioids: results from the JUSTSO European Project”

Antonis Goulas, MD, PhD
Aristotle University of Thessaloniki | Greece
“(Pharmaco)genetics of opiate abuse disorder”

Amira Guirguis, PhD, MPharm
Swansea University | UK
“Drug checking and targeted interventions”

Alejandro Higuera Matas, PhD
National University for Distance Learning (UNED), Madrid | Spain
“Animal models for pharmacological studies on NPS”

Åse Marit Leere Øiestad, PhD
Oslo University Hospital | Norway
“Forensic toxicological analysis of new psychoactive substances – a never-ending struggle to keep up”

Matteo Marti, PhD
University of Ferrara, Italy
“Pharmaco-toxicology of NPS: Focus on Synthetic cannabinoids”

Norbert Scherbaum, MD
LVR-Hospital Essen, University Duisburg-Essen, Germany
“New Synthetic Opioids in Western Germany”

Fabrizio Schifano, MD, FRCPsych
Psychopharmacology, Drug Misuse & NPS Research Unit | University of Hertfordshire | UK
“The e-psychonauts’ psychopharmacology; anthropological, theoretical and clinical issues”

Marta Torrens, MD, PhD
IMIM-Hospital del Mar, Universitat Autònoma Barcelona and Universitat de Vic – Universitat Central de Catalunya | Spain
“New Synthetic opioids: where we are in EU”

Marthe Vanderputte, PhD student
Ghent University | Belgium
“Looks don’t matter, it’s what you do that counts: Activity-based characterization, prioritization, and detection of new synthetic opioids”

Aviv M. Weinstein, MD
Ariel University | Israel
“The effects of synthetic cannabinoids on cognitive function, brain imaging in fMRI and mental health”

DOWNLOAD THE FINAL PROGRAM